About Sellwell

Sellwell Pharmaceuticals was established as a partnership concern in the beginning of the year 1987. It was converted into a Private Limited Company in 1990 and later became a Public Limited Company in 1995. Since March 1987, the company’s products have been well known and trusted in the market for their quality and reliability.

In recognition of its strong commitment to quality management, Sellwell Pharmaceuticals Ltd. has been awarded the ISO 9001:2015 Certification in June 2023.

The Quality Management System of the company has been assessed and found to be in accordance with the requirements of ISO 9001:2015 for the following scope:

Manufacturing, Marketing and Export of Injections, Tablets, Powders for Injections & Powders.

The company started production of Parenteral Preparations, Ophthalmic Preparations, and Tablets in 1987. Over the years, the company has established a strong presence in both Animal Health and Human healthcare products.

For more than 20 years, Sellwell has manufactured products for several reputed companies such as:

• M/s US Vitamins
• M/s Crossland (A Division of Ranbaxy)
• M/s Merind Ltd.
• M/s Wockhardt Ltd.
• M/s Cadila Pharmaceuticals Ltd.
• M/s Vetoquinol India Animal Health Pvt. Ltd.
• M/s Plethico Pharmaceuticals Ltd.

The unit is equipped with complete infrastructure facilities including:

• Transformer power station
• Water storage and treatment facility with a closed-loop system
• Properly constructed plant and machinery
• Air Handling Units (AHU)
• Effluent Treatment Plant (ETP)

The unit has qualified, competent, experienced, and well-trained personnel to handle production efficiently and maintain quality standards.

Sellwell has always endeavored to provide quality products at affordable prices. It is this strong commitment to quality, compliance, and customer satisfaction that has enabled Sellwell not just to survive, but to grow consistently since its inception in 1987.